Email for Cannabis & CBD Brands That Stays Compliant and Builds Trust
Cannabis and CBD email is one of the most regulated categories in DTC, and it starts with the platform. Klaviyo's acceptable use policy (April 2026) prohibits CBD and cannabis on SMS in the US and Canada and reviews other controlled-substance use case by case, and US SMS carriers filter the category too. Omnisend's policy (April 2026) bars cannabis, THC and CBD from SMS as well, so the program is email only in the US and Canada. We check your catalogue against each platform's current policy before building anything, then run programs that respect the rules on language, claims, age gating and state-by-state shipping while still using segmentation, automation and education to drive revenue.
/ Free Audit
Get your free cannabis & CBD email audit
Drop your store URL and email. We'll review your email program and send a written 90-day revenue roadmap within 24 hours. No obligation.
Trusted by
800+ brands
Email marketing for cannabis & CBD brands: the problems we fix.
These are the problems that make cannabis & CBD email different from other categories, and the specific ways we address each one.
Strict regulatory rules on health claims and language
/ Solution
Every claim is written as structure/function language rather than a disease claim. Copy is written to avoid disease claims and flagged for your regulatory review.
Age verification at opt-in and purchase
/ Solution
Age gates at opt-in, cart and checkout. Email follows your 18+ or 21+ access rules, and profiles under 21 are suppressed where you collect date of birth.
State-by-state shipping legality varies
/ Solution
Geographic segmentation respects ship-to-state rules. Customers in restricted states see content for products legal in their state, no cross-promotion of restricted SKUs.
New customers need education, not promotion
/ Solution
Education-led welcome sequences: product type explanations (CBD, CBG, CBN, hemp), how to use each format, and what the lab reports show. Promotional sends come after trust is established.
Flows we build for cannabis & CBD brands.
Every flow is built around the cannabis & CBD customer lifecycle, from first discovery to long-term retention.
Education-First Welcome Series
Covers products, formats and how to use them. Every claim written to avoid disease language and flagged for your regulatory review. No "cures anxiety" or "eliminates pain" language anywhere.
Dosage + Use-Case Post-Purchase
Product-specific usage guidance sent post-purchase. Builds trust with new users uncertain about dosing, drives correct usage, drives reorder rate.
Replenishment Flow
Daily-use products (tinctures, capsules) replenished on their consumption cycle; topicals on usage frequency.
Subscription / Auto-Reorder Conversion
For brands with subscription offerings: triggered after second purchase, with flexibility and discreet shipping prominently featured.
New Product Launch by Use-Case Segment
Each customer segment gets relevant new launches based on the format and product type they buy, not catalogue blasts.
Win-Back with Education Refresh
Lapsed customers re-engaged with updated product information, new lab results or a different format. Education-driven, not discount-driven, given category constraints.
The rules that shape a CBD email program.
Platform first. Klaviyo's acceptable use policy (updated 9 April 2026) bars CBD, cannabis and THC from SMS on US and Canadian short codes and toll-free numbers, and reviews other controlled-substance uses case by case. Omnisend's policy (updated 30 April 2026) bars cannabis, THC and CBD from SMS. Neither lists CBD among the products prohibited on email, but Klaviyo reserves the right to restrict controlled-substance use cases, so we get the platform's confirmation for your catalogue before we build. The program is email only in the US and Canada.
Federal hemp rules are changing. The redefinition of hemp passed in November 2025 limits hemp-derived products to 0.4 mg of total THC per container. It was due to take effect on 12 November 2026; a short-term funding law signed on 2 September 2026 moved the date to 11 December 2026 (as of October 2026). If your catalogue includes THC products, check the date in force before you plan Q4 sends, and keep products that will not be legal out of anything scheduled after it.
This is a US program. In Australia, advertising medicinal cannabis to the public is prohibited under the TGA's rules, so nothing on this page describes an Australian offer. None of this is legal advice.
Sources: Klaviyo: acceptable use policy (9 Apr 2026), Omnisend: acceptable use policy (30 Apr 2026), Akerman: Congress approves one-month delay of federal hemp-THC restrictions (2 Sep 2026), TGA: advertising medicinal cannabis products is prohibited.
/ Next steps
Start with a free audit. Fixed-scope projects typically run $3-15K USD, and monthly retainers typically $3-12K USD, month to month with 30 days' notice. Published ranges are in USD.
/ Related guides
/ Other verticals
Running a cannabis & CBD brand?
Free audit. We measure your flows, segmentation, and campaigns, and show you exactly what's missing for cannabis & CBD brands.
Or browse all verticals →/ Free Audit
Get your free cannabis & CBD email audit
Drop your store URL and email. We'll review your email program and send a written 90-day revenue roadmap within 24 hours. No obligation.